Aug 2026· PLOS mental health· Vol 3, pp. e0000686· 0 citations· 48 references
Medicine
TL;DR
Behavioural and socio-environmental modalities demonstrate strong predictive value for forecasting outcomes in UHR within multimodal AI frameworks.
Abstract
Early identification of individuals at risk of developing psychosis enables timely intervention and better clinical outcomes. Current approach relies on clinical assessments, such as the Comprehensive Assessment for At‑Risk Mental States (CAARMS), which provides an Ultra‑High‑Risk (UHR) classification but have limited predictive precision. Artificial intelligence (AI) models integrating neuroimaging, clinical, genetic, and biomolecular data show promise for improving prognostic accuracy, yet their clinical applicability remains uncertain. We systematically evaluated the contribution of six data modalities, ranging from socio‑environmental factors to polygenic risk scores, using data from 56 UHR participants in the Longitudinal Youth at‑Risk Study (LYRIKS) cohort. Modalities were iteratively included and excluded to generate candidate models tested on two tasks: (1) predicting transition to psychosis within 12 months and (2) predicting remission from UHR status within the same period. Statistical significance was assessed via permutation testing. Of the 56 UHR participants, 12 developed psychosis and 26 achieved remission from UHR status. The model combining CAARMS, socio-environmental risk factors, and social functioning (CAARMS + RISK + HiSoC) achieved the best overall performance for both predicting conversion (MCC = 0.71, SP = 0.93, SE = 0.78) and remission (MCC = 0.64, SP = 0.82, SE = 0.77), and was the only model to significantly outperform null models in the conversion task. Behavioural and socio‑environmental modalities demonstrate strong predictive value for forecasting outcomes in UHR within multimodal AI frameworks. While molecular and genetic modalities remain promising, further advances are needed to translate their high‑dimensional complexity into clinically useful predictive tools.
Individuals at Clinical High Risk for Psychosis (CHR-P) show highly variable outcomes, with approximately one-third achieving remission from their CHR-P state at follow-up. Understanding which factors are associated with remission is crucial for refining risk stratification and optimising early interventions in thi...
Cecilia Sanjuan-Ortiz, N. Laherran-Cantera, C. Aymerich et al.· Schizophrenia· 0 citations
Background: Clinical high-risk states for psychosis (CHR-P) are associated with heterogeneous symptomatic and functional outcomes, only one of which is transition to psychosis. Objective: To propose a structured approach to current care needs and longitudinal clinical formulation alongside established syndromic assessm...
O. Vasiliu, Ileana Marinescu, A. Mangalagiu et al.· Journal of Clinical Medicine· 0 citations
Adolescence is a critical period of neurodevelopment during which psychopathological trajectories associated with the risk of psychosis may emerge. The construct of the At-Risk Mental State (ARMS) enables the identification of subclinical presentations preceding psychosis; however, its course and predictors in the gene...
A. Jovani, F. Castellano-García, B. Moliner-Castellano et al.· European Child and Adolescen...· 0 citations
Early detection of individuals at clinical high risk for psychosis (CHR-P) improves access to preventive care. We developed and internally validated the E-DetectioN Tool for Emerging mental disoRders (ENTER), a multimodal digital screener designed to improve community identification of CHR-P compared with an establishe...
D. Oliver, P. Fusar-Poli, G. Brunner et al.· medRxiv· 0 citations
BACKGROUND
Individuals at clinical high risk for psychosis (CHR) present with heterogeneous combinations of positive, negative, and affective symptoms, cognitive difficulties, and functional impairment. However, reproducible multivariate links between this multidomain phenotype and brain morphology remain limited. This...
S. Vieira, Y. Alemán, L. Bici et al.· Biological Psychiatry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.